Targeting Th2-typified immune responses to prevent immunopathology in rheumatic diseases: belittled therapeutic strategies?

Ann Rheum Dis. 2014 Mar;73(3):477-9. doi: 10.1136/annrheumdis-2013-204285. Epub 2013 Dec 9.

Authors

Frederique M Moret¹, Timothy R D J Radstake, Joel A G van Roon

Affiliation

¹ Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, , Utrecht, The Netherlands.

PMID: 24323396
DOI: 10.1136/annrheumdis-2013-204285

No abstract available

Keywords: Autoimmune Diseases; Cytokines; Treatment.

Publication types

Editorial
Comment

MeSH terms

Animals
Arthritis, Experimental / immunology*
Receptors, G-Protein-Coupled / immunology*
Receptors, Histamine / immunology*
Receptors, Histamine H4
Th17 Cells / immunology*

Substances

Hrh4 protein, mouse
Receptors, G-Protein-Coupled
Receptors, Histamine
Receptors, Histamine H4